These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

139 related items for PubMed ID: 2156920

  • 1. Pro-gamma-MSH levels in various disorders of pituitary-adrenal axis.
    Boscaro M, Giacomazzi P, Sonino N, Fallo F, Girard F, Bertagna X, Mantero F.
    J Endocrinol Invest; 1990 Jan; 13(1):29-33. PubMed ID: 2156920
    [Abstract] [Full Text] [Related]

  • 2. Human plasma proopiomelanocortin N-terminal peptide and adrenocorticotropin: circadian rhythm, dexamethasone suppression, and corticotropin-releasing hormone stimulation.
    Motomatsu T, Takahashi H, Ibayashi H, Nobunaga M.
    J Clin Endocrinol Metab; 1984 Sep; 59(3):495-8. PubMed ID: 6086700
    [Abstract] [Full Text] [Related]

  • 3. Effect of atrial natriuretic factor infusion on basal and CRH-stimulated ACTH, cortisol and aldosterone levels in patients with Cushing's or Addison's disease.
    Ambrosi B, Sala C, Bochicchio D, Colombo P, Gazzano G, Fadin C, Morganti A, Faglia G.
    Clin Endocrinol (Oxf); 1994 May; 40(5):589-94. PubMed ID: 8013139
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Corticotropin-releasing factor test in normal subjects and patients with hypothalamic-pituitary-adrenal disorders.
    Nakahara M, Shibasaki T, Shizume K, Kiyosawa Y, Odagiri E, Suda T, Yamaguchi H, Tsushima T, Demura H, Maeda T.
    J Clin Endocrinol Metab; 1983 Nov; 57(5):963-8. PubMed ID: 6311867
    [Abstract] [Full Text] [Related]

  • 7. Plasma immunoreactive proopiomelanocortin peptides and cortisol in normal dogs and dogs with Addison's disease and Cushing's syndrome: basal concentrations.
    Peterson ME, Orth DN, Halmi NS, Zielinski AC, Davis DR, Chavez FT, Drucker WD.
    Endocrinology; 1986 Aug; 119(2):720-30. PubMed ID: 3015556
    [Abstract] [Full Text] [Related]

  • 8. Urinary molecular forms of human N-terminal of proopiomelanocortin: possible deglycosylation and degradation by the kidney.
    Gaspar L, Chan JS, Seidah NG, Chrétien M.
    J Clin Endocrinol Metab; 1984 Oct; 59(4):614-21. PubMed ID: 6480799
    [Abstract] [Full Text] [Related]

  • 9. The effect of sodium valproate in Cushing's disease, Nelson's syndrome and Addison's disease.
    Reincke M, Allolio B, Kaulen D, Jaursch-Hancke C, Winkelmann W.
    Klin Wochenschr; 1988 Aug 01; 66(15):686-9. PubMed ID: 2845188
    [Abstract] [Full Text] [Related]

  • 10. Effects of sodium-valproate administration on plasma ACTH levels in patients with ACTH hypersecretion.
    Ambrosi B, Bochicchio D, Riva E, Faglia G.
    J Endocrinol Invest; 1983 Aug 01; 6(4):305-6. PubMed ID: 6315806
    [Abstract] [Full Text] [Related]

  • 11. Profound amplification of secretory-burst mass and anomalous regularity of ACTH secretory process in patients with Nelson's syndrome compared with Cushing's disease.
    van Aken MO, Pereira AM, van den Berg G, Romijn JA, Veldhuis JD, Roelfsema F.
    Clin Endocrinol (Oxf); 2004 Jun 01; 60(6):765-72. PubMed ID: 15163342
    [Abstract] [Full Text] [Related]

  • 12. Effect of desmopressin on ACTH and cortisol secretion in states of ACTH excess.
    Colombo P, Passini E, Re T, Faglia G, Ambrosi B.
    Clin Endocrinol (Oxf); 1997 Jun 01; 46(6):661-8. PubMed ID: 9274696
    [Abstract] [Full Text] [Related]

  • 13. Diurnal rhythms of proopiomelanocortin-derived N-terminal peptide, beta-lipotropin, beta-endorphin and adrenocorticotropin in normal subjects and in patients with Addison's disease and Cushing's disease.
    Sekiya K, Nawata H, Kato K, Motomatsu T, Ibayashi H.
    Endocrinol Jpn; 1986 Oct 01; 33(5):713-9. PubMed ID: 3030713
    [Abstract] [Full Text] [Related]

  • 14. Normal and abnormal regulation of beta-msh in man.
    Abe K, Nicholson WE, Liddle GW, Orth DN, Island DP.
    J Clin Invest; 1969 Aug 01; 48(8):1580-5. PubMed ID: 4307702
    [Abstract] [Full Text] [Related]

  • 15. Absence of detectable immunoreactive alpha melanocyte stimulating hormone in plasma in various types of Cushing's disease.
    Croughs RJ, Thijssen JH, Mol JA.
    J Endocrinol Invest; 1991 Mar 01; 14(3):197-200. PubMed ID: 1649212
    [Abstract] [Full Text] [Related]

  • 16. Plasma ACTH and cortisol responses to TRF, vasopressin or hypoglycemia in cushing's disease and nelson's syndrome.
    Krieger DT, Luria M.
    J Clin Endocrinol Metab; 1977 Feb 01; 44(2):361-8. PubMed ID: 190254
    [Abstract] [Full Text] [Related]

  • 17. Effects of synthetic corticotropin-releasing factor in normal individuals and in patients with hypothalamic-pituitary-adrenocortical disorders.
    Jørgensen H, Skare S, Frey H, Hanssen KF, Norman N.
    Acta Med Scand; 1985 Feb 01; 218(1):79-84. PubMed ID: 2996312
    [Abstract] [Full Text] [Related]

  • 18. Immunoreactive corticotropin-releasing factor concentrations in cerebrospinal fluid from patients with hypothalamic-pituitary-adrenal disorders.
    Tomori N, Suda T, Tozawa F, Demura H, Shizume K, Mouri T.
    J Clin Endocrinol Metab; 1983 Dec 01; 57(6):1305-7. PubMed ID: 6605358
    [Abstract] [Full Text] [Related]

  • 19. Development of a radioimmunoassay for an amino-terminal peptide of pro-opiocortin containing the gamma-MSH region: measurement and characterization in human plasma.
    Hope J, Ratter SJ, Estivariz FE, McLoughlin L, Lowry PJ.
    Clin Endocrinol (Oxf); 1981 Sep 01; 15(3):221-7. PubMed ID: 6273026
    [Abstract] [Full Text] [Related]

  • 20. Hyperprolactinemia in Cushing's disease and Nelson's syndrome.
    Yamaji T, Ishibashi M, Teramoto A, Fukushima T.
    J Clin Endocrinol Metab; 1984 May 01; 58(5):790-5. PubMed ID: 6323516
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.